Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Gradientech presents QuickMIC® clinical study results

The diagnostics company Gradientech, developing QuickMIC® for ultra-rapid antibiotic susceptibility testing, today announces decisive results from the completed clinical performance evaluation study of QuickMIC and its gram-negative panel. The results exceed the regulatory requirements to achieve a CE-IVD registration.The clinical performance evaluation study of the QuickMIC system is completed with promising results to form the basis for a CE-IVD registration of QuickMIC following the IVD Directive. The study includes 473 bacterial strains of species common in sepsis, whereof 64 are

Report for the First Quarter 2022 in Katalysen Ventures

Summary of report below. Full report available under Investor Relations on Katalysen.com.All figures currencies in SEK unless otherwise specified.Venture development KPIs: · New clients during the period: 4 · Active clients at the end of the period: 11 · Total calculated market value of Katalysen’s portfolio of shares and options at the end of the period: 195 MSEK · Quarterly portfolio growth excluding new cash invested during the period: 5.6% · Value added to the portfolio from new shares and options obtained via non-cash investments during the period:5.4 MSEK

MapsIndoors delivers growth of 87% resulting in a total ARR growth of 55%

MapsPeople A/S | Quarterly report Q1 2022MAY NOT BE PUBLISHED, DISTRIBUTED, OR SUPPLIED OR IN PARTICULAR, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, AUSTRALIA, CANADA, OR JAPAN. This announcement does not constitute an offering circular, Prospectus, or other offer document. No one should purchase or subscribe for any securities in MapsPeople A/S ("MapsPeople" or the "Company") except on the basis of information in the Prospectus published by the Company in connection with the Offering and admission of such securities to trading on Nasdaq First North Premier Growth Market Denmark ("First

Ponsse manufactures its 18,000th forest machine

The 18,000th PONSSE forest machine was completed at Ponsse’s factory in Vieremä. After its handover, the PONSSE Elk will be operated by VMC Bois in France.“The highly demanding harvesting industry calls for solid professional skills, determination and close cooperation. These are also the characteristics of our partnership with VMC Bois. It feels really good to deliver this machine to VMC Bois, and I would like to thank them for our excellent cooperation,” says Marko Mattila, Sales Marketing and Service Director. “We started our cooperation with Ponsse after we purchased a used PONSSE

Felix Schoeller Group at FESPA in Berlin

· New in the portfolio: Environmentally friendly TRANSFER film · Live sublimation: S-RACE® dye sublimation papers to touch · Exhibition: Felix Schoeller Photo Award in the Willy Brandt HouseThe Felix Schoeller Group will be presenting numerous further developments, exciting live applications and the expansion of its diverse product portfolio at the FESPA Global Print Expo from May 31 to June 3, 2022, in Berlin (Booth A24, Hall 4.2). For the speciality paper manufacturer from Osnabrück, Europe's leading trade fair for screen and digital printing, large format printing and textile

Calmark's trial at Södersjukhuset completed

Calmark Sweden AB (publ) announces today that the clinical trial with the product Neo-Bilirubin, which commenced in September 2021 in cooperation with the research entity of the children's hospital Sachsska barn- och ungdomssjukhuset, Södersjukhuset AB, Stockholm, is now successfully completed. All patients have been included and all that remains now is to prepare the final report. Monitoring of the trial was conducted by Scandiavian CRO.The study was conducted at SÖS during the winter months, with an intermission due to the RSV outbreak. Infants with suspected elevated levels of bilirubin

Salsa to Showcase ‘Brazil-ready’ iGaming Solution at Afiliados Brasil

Salsa Technology  is to showcase its ‘Brazil-ready’ iGaming solution at the Afiliados Brasil event being held between 26th-28th May in São Paulo.This will be the first time Salsa has exhibited at the most important LatAm affiliate marketing meeting. Afiliados Brasil is attended by thousands of professionals exploring new online business opportunities and Salsa will be presenting its localised expertise that has shaped the company’s success in the region. “In addition to the regulation of sports betting, whose first licences should be available by the end of

Changes in Tokmanni’s Executive Group

Tokmanni Group Corporation        Stock exchange release        17 May 2022 at 1:00 pmMarkku Pirskanen, Tokmanni’s CFO has decided to leave the company to assume a new position outside the company. Pirskanen, who has served as CFO since 2017, will continue in his position until the beginning of August 2022. Tokmanni will immediately initiate the search process for a new CFO, and further details will be announced in due course. “The decision to leave Tokmanni was a difficult one. Together as a team, we have succeeded in developing and renewing Tokmanni’s business over the years. I want to

Gasum takes its natural gas supply contract to arbitration

Gasum has a long-term gas supply contract with Russian Gazprom Export, the details of which the companies have been negotiating since autumn last year. In April, Gazprom Export sent Gasum a letter, requirering that going forward the payments agreed in the supply contract should be made in rubles instead of euros. In addition, Gazprom Export has made other claims on Gasum regarding the supply contract.Gasum does not accept Gazprom Export's requirement to switch to ruble payments and will consequently not make payments in rubles or under Gazprom Export’s proposed payment arrangement. In

UPM Specialty Papers commissioned study: In 2040 a fifth of all food packaging could still be landfilled or incinerated unless packaging innovations accelerate

(UPM, Helsinki, 17 May 2022 at 13:00 EEST) – A key trend that emerges from a study commissioned by UPM Specialty Papers is that while recycling, reuse and composting of packaging will all increase significantly, a fifth of all food packaging could still find its way to landfill and incineration even in two decades time. Today, food packaging is predominantly plastic and recycling rates are relatively low. While, fibre-based packaging is widely recycled in non-food uses, the industry believes that by 2040 fibre-based packaging will approach circularity as technical development

Kamux Oyj - Managers' Transactions

Kamux Corporation Managers’ Transactions 17.5.2022 at 12:35 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Callardo Capital Oy Position: Chief Executive Officer (X) Legal person (1): Person Discharging Managerial Responsibilities In Issuer Name: Juha Kalliokoski Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 15117/8/8 ____________________________________________ Transaction

Motivation for sports and school go hand in hand for adolescent athletes – male students less interested in school than female students

Adolescent athletes with high motivation for school also have high motivation for sports. Male students tend to be less interested in school than their female peers, a new study from Finland shows.Successfully integrating elite sports with education requires motivation to commit oneself to both domains. In Europe, the EU has instructed its Member States to formulate and adopt national guidelines on dual careers of athletes. Sufficient policy actions are needed in support of combining elite sports with academic education. In Finland, for example, talented and elite adolescent athletes have

Kamux Oyj - Managers' Transactions

Kamux Corporation Managers’ Transactions 17.5.2022 AT 12:30 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Terho Kalliokoski Position: Member of the Board/Deputy member Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 15135/5/4 ____________________________________________ Transaction date: 2022-05-16 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000206750 Nature of the transaction:

One RescueRunner system ordered by Swedish Sea Rescue

The  Swedish Sea Rescue  further strengthen their operational capability in water rescue operations with one RescueRunner system. The  Sea Rescue in Sweden already has many RescueRunners but sees a need for more search- and lifesaving boats.As the boats work well and are extremely stable, which is required in  tough waters, they have now chosen to invest in another system.  Rescue Runner's durable hull and construction allow rescue efforts in both shallow, difficult  and rocky areas. The Sweidh Sea Rescue  choose the RescueRunner system as it enables safe and efficient rescue

Aptahem enters agreement with international clinical CRO for phase 1 studies with Apta-1

Aptahem (publ) announces today that the company has signed an agreement with the clinical contract research organization (CRO) The Centre for Human Drug Research (CHDR) in the Netherlands to perform the upcoming phase 1 studies with Apta-1. By entering this agreement, which follows on the previous Start-Up Agreement, the plans for the phase 1 studies will continue and preparations for the application to the authorities can be initiated.Aptahem is developing Apta-1 as an acute treatment to prevent organ and tissue damages in patients with sepsis or other inflammatory critical conditions.

Secure Bittium Tough Mobile™ 2 Smartphones and Accessories Exhibited at the Astrid User Days Event

Press release Free for publication on May 17, 2022, at 12.00 p.m. (CEST +1) Secure Bittium Tough Mobile™ 2 Smartphones and Accessories Exhibited at the Astrid User Days Event Oulu, Finland, May 17, 2022 – Bittium will showcase its secure smartphones and solutions at the Astrid User Days event on May 18-19, 2022, in Brussels, Belgium. The event is held at LouvExpo, and the products that will be exhibited include the Bittium Tough Mobile™ 2 smartphones, Bittium Secure Suite™ back-end system, and accessories for the smartphone. At the Bittium stand, will be also showcased the use of

First patient randomized in Phase 2 trial in head and neck cancer

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the first patient has been randomized in the company’s proof-of-concept Phase 2 study in patients with squamous cell carcinoma of the head and neck (SCCHN) with the NOX 1 and 4 inhibitor, setanaxib.The trial is a randomized, placebo-controlled, double-blind, proof-of-concept Phase 2 study. It will investigate the effect of setanaxib 800 mg twice daily in conjunction with pembrolizumab 200mg IV, administered every 3 weeks (the standard treatment regimen for this immunotherapy), in

SLP completes another sale and lease back deal

SLP has today acquired a major logistics property in Nässjö, Svedjan 1. The property has a total lettable area of approximately 12,700 sqm. and is currently let to Industrilås i Nässjö AB with a nine-year lease. SLP will take possession of the property on 30 June 2022.The seller of the property is a company within the same group as Industrilås i Nässjö and the transaction has taken place off-market. The underlying property value is approximately SEK 68 million and the property generates a rental value of approxi­mately SEK 4.8 million which is 100 percent indexed.   “We are pleased to be

Scandinavian ChemoTech receives final patent approval in the EU for the tumour specific control unit in our TSE™ platform

The Company has received the final approval for its EU patent which includes the tumour specific control unit and safety features that are crucial for our TSE platform. The innovation is designed to reduce the side effects which normally occur with older electroporation and ablative technologies.This patent further strengthens ChemoTech’s TSE technology and protects the crucial control unit that generates the unique TSE pulse. The control unit helps the treating physicians of both IQwave™ and vetIQure™ to reduce necros[1] and improve apoptosis[2].   The concept of TSE is to establish

There are no items matching the current filter
There are no more items matching the current filter
Back to top